GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,404 Cr | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr | ₹1,158 Cr |
What is the latest Cash and Bank ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹1,404 Cr |
| Mar2024 | ₹1,063 Cr |
| Mar2023 | ₹1,156 Cr |
| Mar2022 | ₹2,485 Cr |
| Mar2021 | ₹1,158 Cr |
How is Cash and Bank of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,404 Cr | 32.01 | |
| Mar2024 | ₹1,063 Cr | -8.02 | |
| Mar2023 | ₹1,156 Cr | -53.47 | |
| Mar2022 | ₹2,485 Cr | 114.56 | |
| Mar2021 | ₹1,158 Cr | - | |
Compare Cash and Bank of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹39,139.0 Cr | -0.5% | -10.1% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -0.5% |
-10.1% |
-17.6% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses